Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Current Computer-Aided Drug Design|May 10, 2016
5-Year Trends in QSAR and its Machine Learning MethodsOleg T Devinyak, Roman B Lesyk
Chemico-Biological Interactions|June 7, 2021
4-Thiazolidinone-based derivatives do not affect differentiation of mouse embryo fibroblasts (3T3-L1 cell line) into adipocytesKonrad A Szychowski, Bartosz Skóra, Anna Kryshchyshyn-Dylevych, et al.
Chemico-Biological Interactions|December 15, 2016
Study of novel anticancer 4-thiazolidinone derivativesKonrad A Szychowski, Marcin L Leja, Danylo V Kaminskyy, et al.
Scientific Reports|July 25, 2019
Anticancer properties of 5Z-(4-fluorobenzylidene)-2-(4-hydroxyphenylamino)-thiazol-4-oneKonrad A Szychowski, Danylo V Kaminskyy, Marcin L Leja, et al.
European Journal of Medicinal Chemistry|October 15, 2017
Anticancer properties of 4-thiazolidinone derivatives depend on peroxisome proliferator-activated receptor gamma (PPARγ)Konrad A Szychowski, Marcin L Leja, Danylo V Kaminskyy, et al.
Croatian Medical Journal|April 24, 2016
Putative anticancer potential of novel 4-thiazolidinone derivatives: cytotoxicity toward rat C6 glioma in vitro and correlation of general toxicity with the balance of free radical oxidation in ratsLesya I Коbylinska, Nataliya M Boiko, Rostyslav R Panchuk, et al.
Croatian Medical Journal|April 15, 2017
Differential pro-apoptotic effects of synthetic 4-thiazolidinone derivative Les-3288, doxorubicin and temozolomide in human glioma U251 cellsLesya I Коbylinska, Olga Yu Klyuchivska, Iryna I Grytsyna, et al.
Pageof 1